NASDAQ:ACON

Aclarion - ACON Stock Forecast, Price & News

$0.83

+0.01 (+1.22%)

(As of 03/24/2023 12:00 AM ET)

Add

Compare

Today's Range: $0.80
▼
$0.83
50-Day Range: $0.55
▼
$0.83
52-Week Range: $0.38
▼
$4.05

Volume: 12,923 shs
Average Volume: 18,640 shs
Market Capitalization: $6.52 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $3.00

Institutional Ownership

Aclarion MarketRank™ Forecast

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 261.4% Upside
$3.00 Price Target
Short Interest: Healthy
1.22% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: N/A
Insider Trading: Acquiring Shares
$12,043 Bought Last Quarter
Proj. Earnings Growth: N/A

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.34 out of 5 stars

3.5

Analyst's Opinion

Consensus Rating
Aclarion has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $3.00, Aclarion has a forecasted upside of 261.4% from its current price of $0.83.
Amount of Analyst Coverage
Aclarion has received no research coverage in the past 90 days.

4.0

Short Interest

Percentage of Shares Shorted
1.22% of the float of Aclarion has been sold short.
Short Interest Ratio / Days to Cover
Aclarion has a short interest ratio ("days to cover") of 1.4, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Aclarion has recently decreased by 0.17%, indicating that investor sentiment is improving.

0.0

Dividend Strength

Dividend Yield
Aclarion does not currently pay a dividend.
Dividend Growth
Aclarion does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for ACON.

3.3

News and Social Media Coverage

News Sentiment
Aclarion has a news sentiment score of 1.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.71 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 1 news article for Aclarion this week, compared to 0 articles on an average week.

3.3

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Aclarion insiders have bought more of their company's stock than they have sold. Specifically, they have bought $12,043.00 in company stock and sold $0.00 in company stock.
Percentage Held by Insiders
22.10% of the stock of Aclarion is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
Only 2.02% of the stock of Aclarion is held by institutions.

0.0

Earnings and Valuation

Price to Book Value per Share Ratio
Aclarion has a P/B Ratio of 3.61. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Aclarion (NASDAQ:ACON) Stock

Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.

Receive ACON Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aclarion and its competitors with MarketBeat's FREE daily newsletter.

ACON Stock News Headlines

March 17, 2023 | americanbankingnews.com

Analyzing Aclarion (NASDAQ:ACON) & Progenity (NASDAQ:PROG)

March 7, 2023 | finance.yahoo.com

Aclarion Announces Alpesh Patel MD MBA as a Key Opinion Leader Physician Advisor

March 26, 2023 | Legacy Research (Affiliate) (Ad)

"Prepare for Five Years of Famine"

Market Wizard who predicted all indexes would be negative in 2022 shares shocking new forecast

February 16, 2023 | finance.yahoo.com

Aclarion to Present at Third Annual Winter Wonderland - Best Ideas Virtual Investor Conference on February 21st - 24th, 2023

February 15, 2023 | finance.yahoo.com

Aclarion Supports Thought Leadership at the 2nd Annual Sonntag Spine Symposium

February 5, 2023 | finance.yahoo.com

Insiders who bought stock earlier this year lose -US$213k as Aclarion, Inc. (NASDAQ:ACON) drops to US$4.7m

January 31, 2023 | finance.yahoo.com

Gregory Basil MD to Join Aclarion as a Key Opinion Leader Surgeon Advisor

January 17, 2023 | finanznachrichten.de

The Investor Summit: Aclarion to Present at the Jan 26th Virtual Investor Summit Microcap Event

March 26, 2023 | Legacy Research (Affiliate) (Ad)

"Prepare for Five Years of Famine"

Market Wizard who predicted all indexes would be negative in 2022 shares shocking new forecast

January 17, 2023 | finance.yahoo.com

Aclarion to Present at the Jan 26th Virtual Investor Summit Microcap Event

January 17, 2023 | finance.yahoo.com

Aclarion Appoints George Frey MD as Seventh Key Opinion Leader Surgeon Advisor

December 22, 2022 | finance.yahoo.com

Dr. Christopher Ames to Join Aclarion as a Key Opinion Leader Surgeon Advisor

December 21, 2022 | finance.yahoo.com

Aclarion’s Key Opinion Leader Program Adds Fifth Surgeon Advisor with Addition of Eric Potts, MD

December 19, 2022 | finance.yahoo.com

Aclarion Adds to Growing Key Opinion Leader Program with Juan Uribe M.D. as a Surgeon Advisor

December 1, 2022 | finance.yahoo.com

Aclarion Adds to Strong Patent Portfolio with Notice of Allowance for New U.S. Patent Application Addressing Key Pain Indicator Biomarker

November 30, 2022 | reuters.com

ACON.OQ - Aclarion Inc | Stock Price & Latest News | Reuters

November 16, 2022 | finance.yahoo.com

Aclarion Third Quarter 2022 Earnings: Revenues Beat Expectations, EPS Lags

October 25, 2022 | finance.yahoo.com

Aclarion, Inc. Releases Updated Investor Presentation In Connection with Appearance at LD Micro Main Event XV

October 24, 2022 | finance.yahoo.com

Dr. Sigurd Berven to join Aclarion as a Key Opinion Leader Surgeon Advisor

October 12, 2022 | finance.yahoo.com

Aclarion To Present at The LD Micro Main Event XV

October 10, 2022 | finanznachrichten.de

Aclarion Inc.: Aclarion Announces Participation at the NASS 37th Annual Meeting

October 10, 2022 | finance.yahoo.com

Aclarion Announces Participation at the NASS 37th Annual Meeting

October 5, 2022 | finanznachrichten.de

Aclarion Inc.: John Keller M.D. to Join Aclarion as a Key Opinion Leader Surgeon Advisor

October 3, 2022 | finance.yahoo.com

John Keller M.D. to Join Aclarion as a Key Opinion Leader Surgeon Advisor

September 20, 2022 | finanznachrichten.de

Aclarion Inc.: Nociscan Selected for Inclusion in Pivotal National Institutes of Health Study for Low Back Pain

September 19, 2022 | finance.yahoo.com

Nociscan Selected for Inclusion in Pivotal National Institutes of Health (NIH) Study for Low Back Pain

August 22, 2022 | msn.com

Peering Into Aclarion's Recent Short Interest

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive ACON Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aclarion and its competitors with MarketBeat's FREE daily newsletter.

ACON Company Calendar

Today: 3/26/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Medical laboratories
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:ACON
CUSIP: N/A
CIK: 1635077
Web: www.aclarion.com
Phone: 833-275-2266
Fax: N/A
Employees: 3
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $3.00
High Stock Price Forecast: $3.00
Low Stock Price Forecast: $3.00
Forecasted Upside/Downside: +261.4%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 1 Analysts

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-7,610,000.00
Net Margins: -12,583.55%
Pretax Margin: -12,583.55%
Return on Equity: N/A
Return on Assets: -206.46%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 1.40
Quick Ratio: 1.40

Sales & Book Value

Annual Sales: $60,000.00
Price / Sales: 108.73
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.23 per share
Price / Book: 3.61

Miscellaneous

Outstanding Shares: 7,860,000
Free Float: 6,124,000
Market Cap: $6.52 million
Optionable: Not Optionable
Beta: N/A

Key Executives

Dr. Jeffrey John Thramann M.D. (Age 58)
Exec. Chairman
Comp: $300k

Mr. Brent Ness (Age 56)
CEO, Pres & Director
Comp: $339.6k

Mr. John Lorbiecki (Age 59)
Chief Financial Officer
Comp: $225k

Mr. Ryan Bond (Age 48)
Chief Strategy Officer
Comp: $202.6k

Key Competitors

View All Competitors

Insiders

View All Insider Transactions

ACON Stock - Frequently Asked Questions

Should I buy or sell Aclarion stock right now?: 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Aclarion in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ACON shares.
View ACON analyst ratings or view top-rated stocks.
What is Aclarion's stock price forecast for 2023?: 1 Wall Street analysts have issued 1-year price targets for Aclarion's shares. Their ACON share price forecasts range from $3.00 to $3.00. On average, they predict the company's stock price to reach $3.00 in the next twelve months. This suggests a possible upside of 261.4% from the stock's current price.
View analysts price targets for ACON or view top-rated stocks among Wall Street analysts.
How have ACON shares performed in 2023?: Aclarion's stock was trading at $0.58 on January 1st, 2023. Since then, ACON shares have increased by 43.1% and is now trading at $0.83.
View the best growth stocks for 2023 here.
When did Aclarion IPO?: (ACON) raised $12 million in an IPO on Friday, April 22nd 2022. The company issued 2,165,000 shares at a price of $4.50-$6.50 per share.

What is Aclarion's stock symbol?: Aclarion trades on the NASDAQ under the ticker symbol "ACON."
How do I buy shares of Aclarion?: Shares of ACON stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Aclarion's stock price today?: One share of ACON stock can currently be purchased for approximately $0.83.
How much money does Aclarion make?: Aclarion (NASDAQ:ACON) has a market capitalization of $6.52 million and generates $60,000.00 in revenue each year.
How can I contact Aclarion?: Aclarion's mailing address is 951 MARINERS ISLAND BLVD STE 300, SAN MATEO CA, 94404. The official website for the company is www.aclarion.com. The company can be reached via phone at 833-275-2266.

This page (NASDAQ:ACON) was last updated on 3/26/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Aclarion - ACON Stock Forecast, Price & News

Aclarion MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Company Ownership

Earnings and Valuation

About Aclarion (NASDAQ:ACON) Stock

ACON Stock News Headlines

ACON Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders

ACON Stock - Frequently Asked Questions

Overall MarketRank^™